Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia

Annals of Hematology

Volumn 81, Issue 10, 2002, Pages 566-569

  Demeter, Judit ^a,c   Messer, Gerald ^b   Schrezenmeier, Hubert ^c,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aplastic anemia; Immunosuppressive treatment; Polymorphism; TNF

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; LYMPHOTOXIN; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA ISOLATION; ENHANCER REGION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CASE-CONTROL STUDIES; CHILD; ENHANCER ELEMENTS (GENETICS); GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LYMPHOTOXIN-ALPHA; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036956560     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0544-6     Document Type: Article

References (24)

1. Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH (1992) Tumor necrosis factor β gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 74:287-291
2. Demeter J, Messer G, Rämisch S, Mee J, di Giovine F, Herrmann F, Schmid M, Porzsolt F (1996) Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with haematological malignancies. Cytokines Mol Ther 2:239-242
3. Demeter J, Porzsolt F, Rämisch S, Schmidt D, Schmid M, Messer G (1997) Polymorphism of the tumor necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukemia. Br J Haematol 97:107-112
4. Frickhofen N, Kaltwasser J, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 324:1297-1304
5. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Hocker P, Huber C, Kalhs P, Knapp W, Koller U (1988) Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72:266-272
6. Hinterberger W, Adolf G, Bettelheim P, Geissler K, Huber C, Irschick E, Kalhs P, Koller U, Lechner K, Meister B (1989) Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood 74:2713-2717
7. Kapustin SI, Popova TI, Lyshchov AA, Imyanitov EN, Blinov MN, Abdulkadyrov KM (2001) HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol 80:66-71
8. Kim TG, Kim HY, Lee SH, Cho Cs, Park SH, Choi HB, Han H, Kim DJ (1996) Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol 46:10-17
9. Marmont AM (1983) The autoimmune myelopathies. Acta Haematol 69:73-97
10. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511
11. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat L Moore RH (1993) Autoimmune renal disease and tumour necrosis factor-β gene polymorphism. Clin Nephrol 40:63-68
12. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 173:209-219
13. Messer G, Wilson AG, Kick GW, Duff GW, Weiss EH, Meurer M (1994) Association of scleroderma. autoantibodies with human leukocyte antigens and TNF genes. In: Nishioka K, Krieg T (eds) Pathogenesis and management of scleroderma and connective tissue disorders. Tokyo Medical and Dental University Publishing, Tokyo, pp 99-107
14. Nakao S, Takamatsu H, Chuhjo T, Ueda M, Shiobara S, Matsuda T, Kaneshige T, Mizoguchi H (1994) Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood 84:4257-4261
15. Nakao S, Matsushima K, Young N (1989) Decreased interleukin 1 production in aplastic anaemia. Br J Haematol 71:431-436
16. Nakao S, Yamaguchi M, Saito M, Yasue S, Shiobara S, Matsuda T, Nitta M, Sasaki M (1992) HLA-DR2 predicts a favorable reponse to cyclosporine therapy in patients with bone marrow failure. Am J Hematol 40:239-240
17. Nakao S, Yamaguchi M, Shiobara. S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T (1992) Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79:2532-2535
18. Rizzo S, Killick SB, Patel S, Ball SE, Wadhwa M, Dilger P, Gordon-Smith EC, Gibson FM (1999) Reduced TGF-beta1 in patients with aplastic anaemia in vivo and in vitro. Br J Haematol 107:797-803
19. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 83:1216-1225
20. Schultz JC, Shahidi NT (1994) Detection of tumor necrosis factor-α in bone marrow plasma and peripheral blood plasma from patients with aplastic anaemia. Am J Haematol 45:32-38
21. Shinohara K, Ayama H, Tanaka M, Matsuda M, Ando S, Tajiri M (1991) Increased production of tumor necrosis factor-alpha by peripheral blood mononuclear cells in the patients with aplastic anemia. Am J Haematol 37:75-79
22. Viale, M, Bacigalupo A, Ferrini S, Nicolin A (1992) Effect of cyclosporin A on T cell clones from severe aplastic anemia: differential sensitivity of TNF and GM-CSF production. Haematologica 77:237-242
23. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
24. Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372